These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29135306)

  • 1. A Calculation Tool and Process to Pre-Position Pharmaceuticals for Anthrax Post-Exposure Prophylaxis.
    Peksa GD; Robbins MJ; Beyer AR; Weber EK; Johnson K
    Health Secur; 2017; 15(6):569-574. PubMed ID: 29135306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical counterbioterrorism: the response to provide anthrax prophylaxis to New York City US Postal Service employees.
    Partridge R; Alexander J; Lawrence T; Suner S
    Ann Emerg Med; 2003 Apr; 41(4):441-6. PubMed ID: 12658240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness comparison of response strategies to a large-scale anthrax attack on the chicago metropolitan area: impact of timing and surge capacity.
    Kyriacou DN; Dobrez D; Parada JP; Steinberg JM; Kahn A; Bennett CL; Schmitt BP
    Biosecur Bioterror; 2012 Sep; 10(3):264-79. PubMed ID: 22845046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccines and bioterrorism: smallpox and anthrax.
    Kimmel SR; Mahoney MC; Zimmerman RK
    J Fam Pract; 2003 Jan; 52(1 Suppl):S56-61. PubMed ID: 12556279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overview of adverse events reported by participants in CDC's anthrax vaccine and antimicrobial availability program.
    Martin SW; Tierney BC; Aranas A; Rosenstein NE; Franzke LH; Apicella L; Marano N; McNeil MM
    Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):393-401. PubMed ID: 15717323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are US jurisdictions prepared to dispense medical countermeasures through open points of dispensing? Findings from a national study.
    Rebmann T; Loux TM; Swick Z; Dolgin H; Reddick D; Wakefield M
    Health Secur; 2015; 13(2):96-105. PubMed ID: 25813973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anthrax postexposure prophylaxis in postal workers, Connecticut, 2001.
    Williams JL; Noviello SS; Griffith KS; Wurtzel H; Hamborsky J; Perz JF; Williams IT; Hadler JL; Swerdlow DL; Ridzon R
    Emerg Infect Dis; 2002 Oct; 8(10):1133-7. PubMed ID: 12396928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-course postexposure antibiotic prophylaxis combined with vaccination protects against experimental inhalational anthrax.
    Vietri NJ; Purcell BK; Lawler JV; Leffel EK; Rico P; Gamble CS; Twenhafel NA; Ivins BE; Heine HS; Sheeler R; Wright ME; Friedlander AM
    Proc Natl Acad Sci U S A; 2006 May; 103(20):7813-6. PubMed ID: 16672361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From the Centers for Disease Control and Prevention. Updated recommendations for antimicrobial prophylaxis among asymptomatic pregnant women after exposure to Bacillus anthracis.
    JAMA; 2001 Nov; 286(19):2396-7. PubMed ID: 11759668
    [No Abstract]   [Full Text] [Related]  

  • 10. Updated recommendations for antimicrobial prophylaxis among asymptomatic pregnant women after exposure to Bacillus anthracis.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(43):960. PubMed ID: 11708594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postexposure Prophylaxis After Possible Anthrax Exposure: Adherence and Adverse Events.
    Nolen LD; Traxler RM; Kharod GA; Kache PA; Katharios-Lanwermeyer S; Hendricks KA; Shadomy SV; Bower WA; Meaney-Delman D; Walke HT
    Health Secur; 2016; 14(6):419-423. PubMed ID: 27898235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From the Centers for Disease Control and Prevention. Update: adverse events associated with anthrax prophylaxis among postal employees--New Jersey, New York City, and the District of Columbia metropolitan area, 2001.
    JAMA; 2001 Dec; 286(23):2935-6. PubMed ID: 11787481
    [No Abstract]   [Full Text] [Related]  

  • 13. Anthrax as a biological weapon: an old disease that poses a new threat.
    Tasota FJ; Henker RA; Hoffman LA
    Crit Care Nurse; 2002 Oct; 22(5):21-32, 34; quiz 35-6. PubMed ID: 12382615
    [No Abstract]   [Full Text] [Related]  

  • 14. Update: adverse events associated with anthrax prophylaxis among postal employees--New Jersey, New York City, and the District of Columbia metropolitan area, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(47):1051-4. PubMed ID: 11808926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Public response to an anthrax attack: reactions to mass prophylaxis in a scenario involving inhalation anthrax from an unidentified source.
    SteelFisher G; Blendon R; Ross LJ; Collins BC; Ben-Porath EN; Bekheit MM; Mailhot JR
    Biosecur Bioterror; 2011 Sep; 9(3):239-50. PubMed ID: 21819225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing mortality from anthrax bioterrorism: strategies for stockpiling and dispensing medical and pharmaceutical supplies.
    Bravata DM; Zaric GS; Holty JE; Brandeau ML; Wilhelm ER; McDonald KM; Owens DK
    Biosecur Bioterror; 2006; 4(3):244-62. PubMed ID: 16999586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prophylaxis and treatment of anthrax.
    Brook I
    Int J Antimicrob Agents; 2002 Nov; 20(5):320-5. PubMed ID: 12431866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mayor, his troops, and the health of a city.
    Tully S
    Fortune; 2001 Nov; 144(11):138-42. PubMed ID: 11816774
    [No Abstract]   [Full Text] [Related]  

  • 19. Patients' request for and emergency physicians' prescription of antimicrobial prophylaxis for anthrax during the 2001 bioterrorism-related outbreak.
    M'ikanatha NM; Julian KG; Kunselman AR; Aber RC; Rankin JT; Lautenbach E
    BMC Public Health; 2005 Jan; 5():2. PubMed ID: 15634353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update: Investigation of bioterrorism-related anthrax and adverse events from antimicrobial prophylaxis.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(44):973-6. PubMed ID: 11724150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.